AngioDynamics Inc reports results for the quarter ended November 30 - Earnings Summary

AngioDynamics

08/01/2025 14:31

* AngioDynamics Inc  ANGO.OQ  reported a quarterly adjusted
loss
of 4 cents​​ per share for the quarter ended November 30, higher
than the same quarter last year, when the company reported EPS
of -5 cents.  The mean expectation of three analysts for the
quarter was for a loss of 11 cents per share. Wall Street
expected results to range from -12 cents to -10 cents per share.
    * Revenue fell 7.9% to $72.85 million from a year ago;
analysts
expected $70.93 million. 
    * AngioDynamics Inc's reported EPS for the quarter was a
loss
of 26 cents​.
    * The company reported a quarterly loss of $10.74 million.
    * AngioDynamics Inc shares had risen by 2.6% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for AngioDynamics Inc
is $13.00 
This summary was machine generated from LSEG data January 8 at
02:30 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Nov. 30 2024      -0.11          -0.04          Beat
 Aug. 31 2024      -0.15          -0.11          Beat
 May. 31 2024      -0.17          -0.06          Beat
 Feb. 29 2024      -0.14          -0.16          Missed